Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
Clinical trial NCT03325881 · COMPLETED
Trial details
- NCT number
- NCT03325881
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-09
- Primary completion
- 2018-06-07
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.